Kazuaki Chikamatsu

22PUBLICATIONS
23CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Infant and child healthCancer diagnosisCancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (22)

|Sep 06, 2026
Systemic inflammatory indices primarily reflect tumor burden rather than independently predict prognosis in HPV-associated oropharyngeal squamous cell carcinoma.

|Aug 27, 2026
Pretreatment L3 Skeletal Muscle Index Is Associated with Severe Oral Intake Impairment and a Longer Treatment-to-Discharge Interval in Patients with Head and Neck Squamous Cell Carcinoma Receiving Definitive Chemoradiotherapy.

|Aug 20, 2026
Myofibroblast-Like CAFs in Metastatic Lymph Nodes Drive Tumor Stemness and Poor Prognosis in Head and Neck Cancer.

|Jul 28, 2026
Quantitative Association Between Otorrhea Frequency and Sensorineural Hearing Risk in Pediatric Chronic Otitis Media.

|May 26, 2026
SLC39A13 Defines Myofibroblastic Activation and Immunosuppressive Tumor Microenvironment in Head and Neck Squamous Cell Carcinoma.

|Jan 28, 2026
Cancer-Associated Fibroblast Heterogeneity Shapes Prognosis and Immune Landscapes in Head and Neck Squamous Cell Carcinoma.

Hideyuki Takahashi, Hiroyuki Hagiwara, Hiroe Tada

Pageof 4

Frequent Collaborators

11 joint publications

Hideyuki Takahashi

4 joint publications

Masaomi Motegi

2 joint publications

Toshiyuki Matsuyama

2 joint publications

Yuichi Tomidokoro